Eager to get in on new drugs at their start, GlaxoSmithKline is stepping up its efforts to invest in early-stage ventures that might just pay off big down the road.
The company is launching a new venture fund and appointing top-level exec Russell Greig to run it, a Glaxo spokesman said Tuesday. Greig (pictured) previously ran [...]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment